MicroPort Scientific Corp. (HK:0853)
:0853
Top Page
MicroPort Scientific
(0853)
Select Model
Select Model
Rating:46Neutral
Price Target:
HK$12.50
▲(7.11% Upside)
Action:UpgradedDate:12/03/25
The overall stock score is primarily impacted by significant financial challenges, including persistent losses and liquidity issues. Technical analysis provides a slightly more balanced view, but the negative valuation metrics further weigh down the score. The absence of earnings call insights and corporate events means these factors do not influence the score.
Positive Factors
Product Diversification
A broad product portfolio across cardiovascular, orthopedics and neurosurgery reduces reliance on any single market and supports multiple durable revenue streams. This diversification aids resilience to sector-specific cycles and creates cross-selling and bundled-service opportunities over months to years.
Negative Factors
Persistent Unprofitability
Sustained negative EBIT and net losses indicate structural operational inefficiencies. Ongoing unprofitability constrains internal reinvestment, undermines margin sustainability, and forces dependence on external capital, which can impede strategic initiatives and long-term competitiveness.
Read all positive and negative factors
Positive Factors
Negative Factors
Product Diversification
A broad product portfolio across cardiovascular, orthopedics and neurosurgery reduces reliance on any single market and supports multiple durable revenue streams. This diversification aids resilience to sector-specific cycles and creates cross-selling and bundled-service opportunities over months to years.
Read all positive factors
MicroPort Scientific (0853) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$17.58B
Dividend YieldN/A
Average Volume (3M)25.37M
Price to Earnings (P/E)―
Beta (1Y)1.72
Revenue Growth-1.04%
EPS Growth60.66%
CountryHK
Employees6,347
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.39
Shares Outstanding1,917,257,700
10 Day Avg. Volume21,967,342
30 Day Avg. Volume25,373,873
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)2.40
Price to Sales (P/S)1.40
P/FCF Ratio-9.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.05
Revenue Forecast (FY)HK$1.23B
MicroPort Scientific Business Overview & Revenue Model
Company Description
MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The co...
How the Company Makes Money
MicroPort Scientific generates revenue through the sale of its medical devices across various sectors, including cardiovascular, orthopedics, and neurosurgery. The company has established key revenue streams from direct sales to hospitals and heal...
MicroPort Scientific Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.02B | 1.03B | 950.73M | 840.83M | 778.64M | 648.73M |
| Gross Profit | 552.09M | 574.09M | 532.10M | 501.77M | 491.77M | 436.03M |
| EBITDA | -13.83M | -45.30M | -382.54M | -430.26M | -256.35M | -106.87M |
| Net Income | -163.81M | -214.04M | -477.63M | -436.51M | -276.48M | -191.25M |
Balance Sheet | ||||||
| Total Assets | 3.77B | 3.63B | 3.93B | 3.99B | 4.38B | 2.47B |
| Cash, Cash Equivalents and Short-Term Investments | 957.62M | 974.48M | 1.06B | 1.24B | 1.75B | 1.00B |
| Total Debt | 1.76B | 1.69B | 1.70B | 1.47B | 1.24B | 296.31M |
| Total Liabilities | 2.59B | 2.49B | 2.53B | 2.20B | 2.16B | 1.08B |
| Stockholders Equity | 623.12M | 603.47M | 757.82M | 1.14B | 1.49B | 1.13B |
Cash Flow | ||||||
| Free Cash Flow | -83.89M | -158.10M | -430.99M | -600.58M | -505.45M | -143.58M |
| Operating Cash Flow | -27.76M | -49.67M | -231.87M | -343.30M | -257.53M | -23.20M |
| Investing Cash Flow | 16.02M | -149.73M | -376.81M | -412.75M | -655.74M | -148.13M |
| Financing Cash Flow | 37.18M | -97.92M | 434.90M | 273.00M | 1.66B | 846.89M |
MicroPort Scientific Technical Analysis
Negative
11.67
Price Trends
10.75
Negative
10.89
Negative
11.40
Negative
Market Momentum
-0.35
Positive
38.06
Neutral
41.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0853, the sentiment is Negative. The current price of 11.67 is above the 20-day moving average (MA) of 9.88, above the 50-day MA of 10.75, and above the 200-day MA of 11.40, indicating a bearish trend. The MACD of -0.35 indicates Positive momentum. The RSI at 38.06 is Neutral, neither overbought nor oversold. The STOCH value of 41.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0853.
MicroPort Scientific Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$7.21B | 17.31 | 11.91% | 1.26% | 25.18% | 55.79% | |
69 Neutral | HK$7.89B | 19.30 | 9.39% | 1.88% | 14.56% | 61.60% | |
69 Neutral | HK$6.32B | 31.02 | 11.84% | 1.50% | -5.18% | -9.69% | |
57 Neutral | HK$7.86B | 36.52 | 1.98% | ― | 3.42% | -70.82% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | HK$17.58B | -9.88 | -26.71% | ― | -1.04% | 60.66% | |
46 Neutral | HK$27.29B | -91.69 | -117.51% | ― | 112.97% | 37.70% |
* Healthcare Sector Average
HK:0853
MicroPort Scientific
9.17
2.61
39.79%
HK:1302
LifeTech Scientific Corporation
1.82
0.51
38.93%
HK:1789
AK Medical Holdings Ltd.
6.43
1.11
20.86%
HK:1858
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
13.07
4.43
51.27%
HK:2172
MicroPort NeuroTech Limited
10.81
1.72
18.92%
HK:2252
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
26.46
12.82
93.99%
MicroPort Scientific Corporate Events
MicroPort Scientific Flags Return to Profit on Overseas Growth and Cost Cuts
Jan 22, 2026
MicroPort Scientific has issued a positive profit alert, stating that it expects to swing to a net profit of at least US$20 million for the year ended 31 December 2025, compared with an audited net loss of about US$268 million a year earlier. The ...
MicroPort Deconsolidates Neuro Device Subsidiary After Loss of Board Control
Dec 30, 2025
MicroPort Scientific has deconsolidated its subsidiary MicroPort NeuroScientific Corporation after the appointment of an independent non-executive director shifted the balance of control on the Target Company’s board, leaving MicroPort with ...
MicroPort Scientific Announces Strategic Merger to Enhance Competitiveness in Cardiovascular Devices
Dec 15, 2025
MicroPort Scientific Corporation announced the approval of a strategic merger between its CRM business and MicroPort CardioFlow, expected to be completed by December 19, 2025. This merger aims to optimize resource allocation, enhance competitivene...
MicroPort Scientific Reports Mixed Financial Results for Endovastec
Oct 29, 2025
MicroPort Scientific has released the unaudited financial results for its subsidiary, Shanghai MicroPort Endovascular MedTech (Endovastec), for the nine months ending September 30, 2025. The results show a modest revenue increase of 4.66% compared...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.